Literature DB >> 24369382

The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation.

Martial Mallaret1, Matthis Synofzik, Jaeho Lee, Cari A Sagum, Muhammad Mahajnah, Rajech Sharkia, Nathalie Drouot, Mathilde Renaud, Fabrice A C Klein, Mathieu Anheim, Christine Tranchant, Cyril Mignot, Jean-Louis Mandel, Mark Bedford, Peter Bauer, Mustafa A Salih, Rebecca Schüle, Ludger Schöls, C Marcelo Aldaz, Michel Koenig.   

Abstract

We previously localized a new form of recessive ataxia with generalized tonic-clonic epilepsy and mental retardation to a 19 Mb interval in 16q21-q23 by homozygosity mapping of a large consanguineous Saudi Arabian family. We now report the identification by whole exome sequencing of the missense mutation changing proline 47 into threonine in the first WW domain of the WW domain containing oxidoreductase gene, WWOX, located in the linkage interval. Proline 47 is a highly conserved residue that is part of the WW motif consensus sequence and is part of the hydrophobic core that stabilizes the WW fold. We demonstrate that proline 47 is a key amino acid essential for maintaining the WWOX protein fully functional, with its mutation into a threonine resulting in a loss of peptide interaction for the first WW domain. We also identified another highly conserved homozygous WWOX mutation changing glycine 372 to arginine in a second consanguineous family. The phenotype closely resembled the index family, presenting with generalized tonic-clonic epilepsy, mental retardation and ataxia, but also included prominent upper motor neuron disease. Moreover, we observed that the short-lived Wwox knock-out mouse display spontaneous and audiogenic seizures, a phenotype previously observed in the spontaneous Wwox mutant rat presenting with ataxia and epilepsy, indicating that homozygous WWOX mutations in different species causes cerebellar ataxia associated with epilepsy.

Entities:  

Keywords:  WW domain; WWOX; ataxia; hereditary spastic paraplegia; tonic-clonic epilepsy

Mesh:

Substances:

Year:  2013        PMID: 24369382      PMCID: PMC3914474          DOI: 10.1093/brain/awt338

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

1.  A protein-domain microarray identifies novel protein-protein interactions.

Authors:  Alexsandra Espejo; Jocelyn Côté; Andrzej Bednarek; Stephane Richard; Mark T Bedford
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

2.  WWOX protein expression in normal human tissues.

Authors:  Maria I Nunez; John Ludes-Meyers; C Marcelo Aldaz
Journal:  J Mol Histol       Date:  2006-08-29       Impact factor: 2.611

3.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

4.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide.

Authors:  M J Macias; M Hyvönen; E Baraldi; J Schultz; M Sudol; M Saraste; H Oschkinat
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

Review 5.  WWOX in biological control and tumorigenesis.

Authors:  Rami I Aqeilan; Carlo M Croce
Journal:  J Cell Physiol       Date:  2007-08       Impact factor: 6.384

6.  Targeted deletion of Wwox reveals a tumor suppressor function.

Authors:  Rami I Aqeilan; Francesco Trapasso; Sadiq Hussain; Stefan Costinean; Dean Marshall; Yuri Pekarsky; John P Hagan; Nicola Zanesi; Mohamed Kaou; Gary S Stein; Jane B Lian; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

7.  A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination.

Authors:  Angel Ramirez; Angustias Page; Alberto Gandarillas; Jennifer Zanet; Sophie Pibre; Miguel Vidal; Laura Tusell; Anna Genesca; Duncan A Whitaker; David W Melton; Jose L Jorcano
Journal:  Genesis       Date:  2004-05       Impact factor: 2.487

8.  WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Andrzej K Bednarek; Jeff Drake; Mark T Bedford; C Marcelo Aldaz
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

9.  Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C.

Authors:  V A Street; C L Bennett; J D Goldy; A J Shirk; K A Kleopa; B L Tempel; H P Lipe; S S Scherer; T D Bird; P F Chance
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

10.  Phi-analysis at the experimental limits: mechanism of beta-hairpin formation.

Authors:  Miriana Petrovich; Amanda L Jonsson; Neil Ferguson; Valerie Daggett; Alan R Fersht
Journal:  J Mol Biol       Date:  2006-06-06       Impact factor: 5.469

View more
  46 in total

Review 1.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

2.  WWOX-associated encephalopathies: identification of the phenotypic spectrum and the resulting genotype-phenotype correlation.

Authors:  Hepsen Mine Serin; Erdem Simsek; Esra Isik; Sarenur Gokben
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

3.  Novel mutations in WWOX, RARS2, and C10orf2 genes in consanguineous Arab families with intellectual disability.

Authors:  Asem M Alkhateeb; Samah K Aburahma; Wesal Habbab; I Richard Thompson
Journal:  Metab Brain Dis       Date:  2016-04-28       Impact factor: 3.584

Review 4.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

5.  A novel whole exon deletion in WWOX gene causes early epilepsy, intellectual disability and optic atrophy.

Authors:  Salma Ben-Salem; Aisha M Al-Shamsi; Anne John; Bassam R Ali; Lihadh Al-Gazali
Journal:  J Mol Neurosci       Date:  2014-11-18       Impact factor: 3.444

6.  A novel missense variant in the SDR domain of the WWOX gene leads to complete loss of WWOX protein with early-onset epileptic encephalopathy and severe developmental delay.

Authors:  Jessika Johannsen; Fanny Kortüm; Georg Rosenberger; Kristin Bokelmann; Markus A Schirmer; Jonas Denecke; René Santer
Journal:  Neurogenetics       Date:  2018-05-28       Impact factor: 2.660

Review 7.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

Review 8.  WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer.

Authors:  Robert I Richards; Amanda Choo; Cheng Shoou Lee; Sonia Dayan; Louise O'Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

9.  Introduction to a thematic issue for WWOX.

Authors:  Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03

Review 10.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.